Peer-reviewed veterinary case report
Feline leishmaniosis diagnosis, treatment, and outcomes in 16 cats
By Fernandez-Gallego, Ana et al.·Published in Journal of feline medicine and surgery·2020·Hospital Ars Veterinaria, Spain·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Feline leishmaniosis: diagnosis, treatment and outcome in 16 cats.
- Species:
- cat
Plain-English summary
A group of 16 cats in Spain were diagnosed with leishmaniosis, a disease spread by insect bites, showing symptoms like skin lesions, eye problems, and loss of appetite. Most cats had additional health issues, and while 75% received treatment specifically for leishmaniosis, only about 42% showed improvement. The average survival time for those treated was around 17 months, but it varied depending on other health conditions. This disease can present similarly to what is seen in dogs, but cats often have unique symptoms and may have other underlying health problems.
People also search for: cat leishmaniosis symptoms · treatment for cat skin lesions · why is my cat losing weight
Abstract
OBJECTIVES: Leishmaniosis is a vector-borne disease and in European countries is caused by. Cats are considered secondary reservoirs of the infection in endemic areas. The objective of this retrospective study is to describe the clinical findings, diagnosis, treatment and outcome of feline leishmaniosis (FeL) in 16 cats in Spain. METHODS: Medical records of cats diagnosed with leishmaniosis were retrospectively reviewed for cases that met the following inclusion criteria: identification oforganisms and/or DNA on cytological and/or histological specimens and/or a high anti-antibody titre, compatible clinical findings and pathological abnormalities. RESULTS: Sixteen cats met the inclusion criteria, all of which were living in areas endemic for canine leishmaniosis. Systemic signs were present in 11 cases (68.8%). The most common clinical signs on presentation included cutaneous lesions in 12 cats (75%), ocular disease in six cats (37.5%) and anorexia in six cats (37.5%). A polyclonal gammopathy was noted in 12 cats (85.7%). Non-regenerative anaemia and renal abnormalities were present in six (37.5%) and five patients (31.3%), respectively. In nine cats (56.3%), immunosuppressive conditions/comorbidities were identified. The diagnosis was made in eight of the cats (50%) by cytology, but a combination of diagnostic tests was needed for definitive diagnosis in the remaining patients. Twelve cats (75%) were treated specifically for leishmaniosis. Five of the 12 cats (41.7%) did not improve with treatment. The median survival time in the group of patients treated specifically for leishmaniosis was 17 months. Median survival of patients treated with concomitant diseases was 13 months vs 41 months in those without, although this was not statistically significant ( = 0.557). CONCLUSIONS AND RELEVANCE: Presentation of FeL appears to be similar to canine leishmaniosis but with some specific features: ulcerative and nodular skin lesions are the predominant cutaneous signs; cats with immunosuppressive conditions or coexisting diseases were more commonly present than typically seen in dogs (mainly feline immunodeficiency virus). A combination of diagnostic tests may be needed for definitive diagnosis.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/32053024/